OMRF has answered the call for personal protective equipment donations and is joining the Covid-19 testing efforts.
testing
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
OMRF Genomics Center earns CAP accreditation
OMRF’s Clinical Genomics Center will now be able to offer services to clinicians.
Eisai, OMRF enter autoimmune disease research collaboration
The project is focused on lupus, which affects up to 1.5 million Americans.
Trial participants are unsung heroes of research
Patient volunteers like Phyllis Smith are vital to the drug trial process.